China SXT Pharmaceuticals (SXTC) Total Debt (2018 - 2025)

China SXT Pharmaceuticals' Total Debt history runs 8 years deep, the most recent figure standing at $77577.0 for Q3 2025.

• In Q3 2025, Total Debt fell 37.65% year-over-year to $77577.0; the TTM figure through Sep 2025 stood at $77577.0 (down 37.65% YoY), while the FY2025 annual figure was $105045.0, down 82.78% from the prior year.
• Total Debt was $77577.0 for Q3 2025 at China SXT Pharmaceuticals, down from $105045.0 in the prior quarter.
• In the past five years, Total Debt ranged from a high of $12.2 million in Q1 2021 to a low of $11404.0 in Q1 2022.
• Historically, Total Debt has averaged $1.7 million across 5 years, with a median of $205813.5 in 2023.
• The sharpest annual moves came in 2021 and 2022: Total Debt surged 3373.1% in 2021, then sank 99.91% in 2022.
• A 5-year view of Total Debt shows it stood at $2.1 million in 2021, then sank by 43.04% to $1.2 million in 2022, then tumbled by 89.53% to $126312.0 in 2023, then fell by 1.49% to $124424.0 in 2024, then sank by 37.65% to $77577.0 in 2025.
• The last three Total Debt figures came in at $77577.0 (Q3 2025), $105045.0 (Q1 2025), and $124424.0 (Q3 2024), per Business Quant data.